Innocoll Drug Patent Portfolio
Innocoll owns 2 orange book drugs protected by 8 US patents Given below is the list of Innocoll's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400019 | Sustained release drug delivery systems with reduced impurities and related methods | 12 Jan, 2041 | Active |
| US11771624 | Sustained release drug delivery systems with reduced impurities and related methods | 12 Jan, 2041 | Active |
| US11746141 | Modified collagen | 09 Jan, 2033 | Active |
| USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage | 20 May, 2029 | Active |
| US8153149 | Controlled delivery system | 15 Sep, 2025 | Expired |
| US8153661 | Controlled delivery system | 15 Sep, 2025 | Expired |
| US8753665 | Controlled delivery system | 15 Sep, 2025 | Expired |
| US8846072 | Controlled delivery system | 15 Sep, 2025 | Expired |
Latest Legal Activities on Innocoll's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Innocoll.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Post Issue Communication - Certificate of Correction | 13 Oct, 2023 | US11400019 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2023 | US8153149 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2023 | US8153661 |
|
Email Notification
Critical
| 03 Oct, 2023 | US11771624 |
| Recordation of Patent eGrant | 03 Oct, 2023 | US11771624 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Oct, 2023 | US11771624 |
| Patent eGrant Notification | 03 Oct, 2023 | US11771624 |
| Mail Patent eGrant Notification | 03 Oct, 2023 | US11771624 |
|
Recordation of Patent Grant Mailed
Critical
| 03 Oct, 2023 | US11771624 |
|
Email Notification
Critical
| 15 Sep, 2023 | US11771624 |
|
Issue Notification Mailed
Critical
| 13 Sep, 2023 | US11771624 |
| Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
|
Email Notification
Critical
| 05 Sep, 2023 | US11746141 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Sep, 2023 | US11746141 |
Innocoll's Family Patents
Innocoll Drug List
Given below is the complete list of Innocoll's drugs and the patents protecting them.
1. Posimir
Posimir is protected by 6 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400019 | Sustained release drug delivery systems with reduced impurities and related methods |
12 Jan, 2041
(15 years from now)
| Active |
| US11771624 | Sustained release drug delivery systems with reduced impurities and related methods |
12 Jan, 2041
(15 years from now)
| Active |
| US8153149 | Controlled delivery system |
15 Sep, 2025
(3 months ago)
| Expired |
| US8153661 | Controlled delivery system |
15 Sep, 2025
(3 months ago)
| Expired |
| US8753665 | Controlled delivery system |
15 Sep, 2025
(3 months ago)
| Expired |
| US8846072 | Controlled delivery system |
15 Sep, 2025
(3 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Posimir's drug page
2. Xaracoll
Xaracoll is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11746141 | Modified collagen |
09 Jan, 2033
(7 years from now)
| Active |
| USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
20 May, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xaracoll's drug page